Article

STAAR ICL approved for market in China

Monrovia, CA-The People's Republic of China's State Food and Drug Administration (SFDA) granted approval to STAAR Surgical Co. to market its Visian implantable collamer lens (ICL) in China.

Monrovia, CA-The People's Republic of China's State Food and Drug Administration (SFDA) granted approval to STAAR Surgical Co. to market its Visian implantable collamer lens (ICL) in China.

"This approval is an important achievement for STAAR Surgical. It will allow us to enter a market that we believe has the potential to become one of the largest markets for the Visian ICL," said David Bailey, president and chief executive officer of STAAR Surgical. "Currently, China is the second-largest market in the world for the LASIK procedure and there is a higher rate of incidence for myopia and astigmatism in Asian countries compared with the rest of the world. With these two market dynamics, we believe that successful entry into this market could lead to meaningful growth in our overall refractive business."

Bailey added that a training center and regional distribution operation have been established, and was hopeful that the SFDA would approve Visian Toric ICL by the end of the year.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
© 2025 MJH Life Sciences

All rights reserved.